Governmental Measures Target Expanded Access to Affordable Housing 2 days ago Brian Honea’s writing and editing career spans nearly two decades across many forms of media. He served as sports editor for two suburban newspaper chains in the DFW area and has freelanced for such publications as the Yahoo! Contributor Network, Dallas Home Improvement magazine, and the Dallas Morning News. He has written four non-fiction sports books, the latest of which, The Life of Coach Chuck Curtis, was published by the TCU Press in December 2014. A lifelong Texan, Brian received his master’s degree from Amberton University in Garland. Share Save Previous: The Hottest Spots for SFR Investors Are. . . Next: A Victory for Servicers in Super-Priority Lien Fight Sign up for DS News Daily Demand Propels Home Prices Upward 2 days ago Servicers Navigate the Post-Pandemic World 2 days ago Data Provider Black Knight to Acquire Top of Mind 2 days ago The Best Markets For Residential Property Investors 2 days ago The Week Ahead: Nearing the Forbearance Exit 2 days ago Fannie Mae Mortgage Servicers 2016-05-11 Brian Honea in Daily Dose, Featured, Foreclosure, News Governmental Measures Target Expanded Access to Affordable Housing 2 days ago The Best Markets For Residential Property Investors 2 days ago Related Articles Fannie Mae has announced updates to its Servicing Guide involving new proration requirements to allowable attorney foreclosure fees and determining when foreclosure proceedings should be suspended, among other changes.According to Servicing Guide Announcement SVC-2016-04 issued by Fannie Mae on Wednesday, the current requirement is for servicers and law firms to charge reasonably prorated allowable foreclosure attorney fees for the services that were actually provided when a foreclosure proceeding is interrupted or not completed.Fannie Mae said that in order to provide consistency, the Servicing Guide on Prorated Attorney Fees/Reimbursement of Uncollected Fees and Costs has been updated to include new requirements on the prorating of allowable foreclosure fees on mortgage loans backed by Fannie Mae.Servicers are encouraged to implement the new prorated foreclosure attorney fee requirements for both currently active foreclosure matters and new referrals before September 1, 2016. Fannie Mae is requiring servicers to implement the changes for all matters referred to attorneys for the initiation of foreclosure on or after September 1.Another change involved setting a maximum allowable reimbursement limit to servicers for the cost of posting the notice of foreclosure sale at the designated public location in California, as required by state law. The updates to Servicing Guide E-5-07, Other Reimbursable Expenses and Servicing Guide F-1-06, Expense Reimbursement reflect a maximum reimbursement amount of $75 and will apply to all foreclosure referrals on or after July 1.Other changes made include updates to Servicing Guide E-3, 4-01: Suspending Foreclosure Proceedings for Workout Negotiations. The reference to the Post Foreclosure to Referral Solicitation Letter has been removed, and from now on servicers are required to use the foreclosure referral as the consistent point in time for determining when to suspend foreclosure proceedings. While servicers are encouraged to implement the change as soon as possible, they are required to implement it by June 1.Click here to view Fannie Mae’s complete Servicing Guide Announcement released Wednesday. Fannie Mae Announces Updates to Servicing Guide About Author: Brian Honea Tagged with: Fannie Mae Mortgage Servicers Demand Propels Home Prices Upward 2 days ago Data Provider Black Knight to Acquire Top of Mind 2 days ago Servicers Navigate the Post-Pandemic World 2 days ago Print This Post Home / Daily Dose / Fannie Mae Announces Updates to Servicing Guide May 11, 2016 3,537 Views Subscribe
Jens Hildreth is a fun-loving 8-year-old. He smiles a lot. He is on the move – a lot. And he asks questions – a lot! Sam, when is the kid’s library open? Hey Bill, when is your partner coming to the security desk? Jens seems to know everyone at Helen DeVos Children’s Hospital (HDVCH) in Grand Rapids, Michigan.Jens and his dad, Dean Hildreth, visit with the Helen DeVos Children’s Hospital staff. Jens enjoys meeting new and old friends during his trips.Jens is here often. In the past year, he and his parents have made the six-hour flight from their home in Alaska over 10 times so Jens may receive care for his neuroblastoma, a rare pediatric cancer without a cure. At age 4, Jens was diagnosed after doctors found an orange-size tumor wrapped around his kidney. Jens has been through a lot since the difficult surgery to remove the tumor.Right now, Jens is feeling pretty good. He takes medication daily to bolster his immune system and he receives chemotherapy once a month near his home. Remarkably, all of his current treatment is designed specifically for his tumor and his genes – and this means less harsh side effects and a kid who feels well enough to jump all around the hospital to see his friends.Jens receives treatment as part of his involvement in the world’s first precision medicine clinical trial for pediatric cancer run within the Dell Precision Medicine Program, run by the Beat Childhood Cancer Consortium at HDVCH and the Translational Genomics Research Institute (TGen). Jens’s recent bone marrow aspiration test showed cancer cell detection at zero – and that’s a big deal. How did Jens get to this point?Jens plays outside of the Helen DeVos Children’s Hospital. His stuffed monkey, Ivy, is his well-loved travel buddy.Dr. Giselle Sholler, Jens’s doctor in Michigan, asks you to envision a computer monitor with numerous images of DNA and RNA strands, showing the genetic codes causing cancerous tumors to grow. Doctors can then learn how to break these codes by using drugs.This information is made possible after a process called “genomic sequencing,” where a piece of a child’s tumor is studied using very specialized computing technology that can analyze more than 200 billion data points.Dr. Sholler is the director of the Haworth Innovative Therapeutics Clinic at HDVCH. She’s also the director of the pediatric oncology research program there, and the chair of the Beat Childhood Cancer Consortium.Jens’s tumor was analyzed by the TGen bioinformatics team in Phoenix, Arizona. Here, the team uses Dell’s high-performance computing solution to analyze patients’ tumors as part of TGen’s partnership with Dr. Sholler and the Beat Childhood Cancer consortium.While this analysis at TGen is happening, a piece of the tumor is also at the hospital lab, where Dr. Sholler and her team use it to grow more cells in culture, in order to test which drugs the tumor cells respond to.Once this process is complete, a broad team of experts from all over the world convene and talk about the patient’s information – all digitally stored in the KIDS Cloud, a cloud-based Dell solution that enables medical professionals from TGen and all the Beat Childhood Cancer clinical trial sites to collaboratively review information and create treatment plans.“We discuss the patient’s case, the genomics, what DNA mutations do we see… what drugs might target those. Together we come up with a personalized treatment plan,” Dr. Sholler says.Since Dell began its partnership with TGen in 2011, over 150 critically ill patients have received precision medicine-based treatment based on genomic sequencing. Dell provides funding, technology and expertise that enable researchers and doctors to accelerate and improve treatment plans. Recently published trial results show that the precision medicine approach stabilized or reduced tumors in 64 percent of children with neuroblastoma.Mapping one human genomeAccording to Dr. Jeffrey Trent, TGen’s president and research director, if one were to type 60 words a minute, eight hours a day, it would take 50 years to record one human genome, creating a stack of paper as high as the Statue of Liberty — and a single misspelling could cause a disease. Dr. Trent credits TGen, Dell and EMC for forming an IT infrastructure that now allows scientists and clinicians to receive this critical information faster than ever thought possible.Neuroblastoma is an aggressive cancer. Many children relapse. So when doctors discovered Jens’s tumor had returned in 2016, precision medicine was vital to garnering better insights for more effective treatment – that could be prescribed faster.Dell’s funding and technology helped TGen reduce the time it takes to do a whole genome sequencing analysis from multiple weeks to eight hours.Jens’s mom, Joelene Kacena, recalls how this time-saving technology provided hope to her family at a very critical stage.“When doctors are trying to figure out what to do next, you think of the cancer every minute, every hour,” she says. “The anxious part of me was saying, Hey, my kid’s cancer is multiplying and growing as we speak. So when we learned about the precision medicine approach, I was totally wowed.”For Kacena, her son’s experience with precision medicine has meant many positive things. A happier, healthier Jens. The ability to work again at her job in the local library. More laughs shared by all three of her sons, playing together.“He’s better and we’re so, so happy for that,” Kacena says. “I want more families and children to know about this approach and to benefit. I hope this flourishes and flourishes and becomes a natural protocol.”Jens with his mom, Joelene, and dad, Dean. Jens enjoys basketball, computer games, and learning new things.As part of our work with TGen, we learn about remarkable young patients, and their families with extraordinary courage. Meet more of these special people here.Explore more on delltechnologies.com:CUSTOMER STORY: Speed is imperative in the fight against rare diseases. For Translational Genomics Research Institute (TGen) and its Center for Rare Childhood Disorders, the Phoenix-based research and treatment center, shortening the “diagnostic odyssey” is only the beginning.TRAILBLAZERS PODCAST: From X-Rays to wearables, better healthcare means peering deeper into the human body. Join Walter and guests Dr. Daniel Kraft, Reenita Das, Dr. Jeffrey Trent, Anne Wojcicki and Dr. Giselle Sholler as they explore how wellness is becoming more personal, and more proactive.This article shares one example of how Dell is committed to driving human progress by putting our technology and expertise to work where it can do the most good for people and the planet. We call this our Legacy of Good.Explore our FY17 Annual update on our 2020 Legacy of Good Plan at legacyodgood.dell.com.[UPDATE 8/15/2018]On Thursday, August 9, 2018, Jens died at age eight at Helen DeVos Children’s Hospital in Grand Rapids, Michigan. This little warrior from Nome, Alaska, touched so many lives wherever he went. His positive energy was appreciated by anyone he met, including those at DeVos Children’s Hospital and Spectrum Butterworth while he received cancer treatments for his Neuroblastoma. In 2017, while receiving treatment in Grand Rapids, some of us from Dell were able to see first-hand how Jens brought smiles and laughter to strangers, friends, security guards, the hospital librarian – everyone in his path. Jens – and his parents Joelene and Dean – fought his cancer so bravely for over four years. He will be deeply missed.
Posted in orlnashnTagged: 上海24名学生坠楼, 上海419暗香, 上海全套会所, 上海几百元的干磨店一览表, 上海夜生活节感悟, 夜上海论坛JK, 广州上课品茶微信, 爱上海BR, 爱上海JY, 爱上海RL, 苏州芙蓉谁验证过, 高端外卖工作室群.